1. 177Lu-Dotatate plus long-acting octreotide versus high‑dose long-acting octreotide in patients with midgut neuroendocrine tumours (NETTER-1): final overall survival and long-term safety results from an open-label, randomised, controlled, phase 3 trial. Issue 12 (December 2021) Authors: Strosberg, Jonathan R; Caplin, Martyn E; Kunz, Pamela L; Ruszniewski, Philippe B; Bodei, Lisa; Hendifar, Andrew; Mittra, Erik; Wolin, Edward M; Yao, James C; Pavel, Marianne E; Grande, Enrique; Van Cutsem, Eric; Seregni, Ettore; Duarte, Hugo; Gericke, Germo; Bartalotta, Amy; Mariani, Maurizio F; ... Journal: Lancet oncology Issue: Volume 22:Issue 12(2021) Page Start: 1752 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A Clinicopathological Study of Malignant Insulinoma in a Contemporary Series. Issue 1 (January 2017) Authors: Yu, Run; Nissen, Nicholas N.; Hendifar, Andrew; Tang, Laura; Song, Yu-Li; Chen, Yuan-Jia; Fan, Xuemo Journal: Pancreas Issue: Volume 46:Issue 1(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A Meta-Analysis of Osteosarcoma Outcomes in the Modern Medical Era. (18th March 2012) Authors: Allison, Daniel C.; Carney, Scott C.; Ahlmann, Elke R.; Hendifar, Andrew; Chawla, Sant; Fedenko, Alex; Angeles, Constance; Menendez, Lawrence R. Other Names: Casanova Jose Academic Editor. Journal: Sarcoma Issue: Volume 2012(2012) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A Novel EUS‐Guided Intratumoral Delivery of Submicron Particle Paclitaxel (SPP) for the Treatment of Locally Advanced Pancreatic Cancer (LA‐PAC): A Prospective Safety, Tolerability and Preliminary Efficiency Study: 6. (October 2019) Authors: Lo, Simon; Hendifar, Andrew; Sharma, Neil; Othman, Mohamed; Mendoza‐Ladd, Antonio; Verco, Shelagh; Verco, James; diZerega, Gere Journal: American journal of gastroenterology Issue: Volume 114 (2019)ACG Abstracts 1:Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. ALK Inhibitors in Patients With ALK Fusion–Positive GI Cancers: An International Data Set and a Molecular Case Series. (27th April 2022) Authors: Ambrosini, Margherita; Del Re, Marzia; Manca, Paolo; Hendifar, Andrew; Drilon, Alexander; Harada, Guilherme; Ree, Anne Hansen; Klempner, Samuel; Mælandsmo, Gunhild Mari; Flatmark, Kjersti; Russnes, Hege G.; Cleary, James M.; Singh, Harshabad; Sottotetti, Elisa; Martinetti, Antonia; Randon, Giovan... Journal: JCO precision oncology Issue: Volume 6(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Biomarker-driven EGFR therapy improves outcomes in patients with metastatic colorectal cancer. Issue 9 (September 2014) Authors: Hendifar, Andrew; Tan, Carlyn-Rose; Annamalai, Anand; Tuli, Richard Journal: Expert review of anticancer therapy Issue: Volume 14:Issue 9(2014) Page Start: 1051 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Biomarker-driven EGFR therapy improves outcomes in patients with metastatic colorectal cancer. Issue 9 (September 2014) Authors: Hendifar, Andrew; Tan, Carlyn-Rose; Annamalai, Anand; Tuli, Richard Journal: Expert review of anticancer therapy Issue: Volume 14:Issue 9(2014) Page Start: 1051 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Combination systemic therapies with immune checkpoint inhibitors in pancreatic cancer: overcoming resistance to single‐agent checkpoint blockade. Issue 1 (8th October 2018) Authors: Gong, Jun; Hendifar, Andrew; Tuli, Richard; Chuang, Jeremy; Cho, May; Chung, Vincent; Li, Daneng; Salgia, Ravi Journal: Clinical and translational medicine Issue: Volume 7:Issue 1(2018) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Combined morphologic and metabolic pipeline for Positron emission tomography/computed tomography based radiotherapy response evaluation in locally advanced pancreatic adenocarcinoma. (January 2019) Authors: Lao, Yi; David, John; Torosian, Arman; Placencio, Veronica; Wang, Yalin; Hendifar, Andrew; Yang, Wensha; Tuli, Richard Journal: Physics and imaging in radiation oncology Issue: Volume 9(2019) Page Start: 28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Comparing Physician and Nurse Eastern Cooperative Oncology Group Performance Status (ECOG‐PS) Ratings as Predictors of Clinical Outcomes in Patients with Cancer. (21st June 2019) Authors: Neeman, Elad; Gresham, Gillian; Ovasapians, Navasard; Hendifar, Andrew; Tuli, Richard; Figlin, Robert; Shinde, Arvind Journal: Oncologist Issue: Volume 24:Number 12(2019) Page Start: e1460 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗